Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C

NCT01140997 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Ypeginterferon alfa-2b
DRUG: Peginterferon alfa-2a

Sponsor

Xiamen Amoytop Biotech Co., Ltd.

Collaborators

[object Object]